
M. Lia Palomba, MD
Lymphoma Specialist & Cellular Therapist
Titles
Attending Physician
Clinical Expertise
Hodgkin and Non-Hodgkin Lymphomas; Chronic Lymphocytic Leukemia (CLL); Waldenström’s Macroglobulinemia; Translational Studies in Lymphoma
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Palomba accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-608-3711 Office Phone
- Speaks English and Italian

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, University of Pavia
Residencies
Internal Medicine - Mount Auburn Hospital
Fellowships
Hematology - IRCCS Hospital San Mateo; Hematology/Oncology - Memorial Sloan Kettering Cancer Center; Medicine - Weill Cornell Medical College
Board Certifications
Hematology (Italy); Internal Medicine; Medical Oncology
I am a hematologist-oncologist who specializes in the study and treatment of lymphoma. My work focuses on the development of novel therapies for patients with B cell lymphoma, including indolent lymphomas (follicular, marginal zone, small lymphocytic), Waldenström’s macroglobulinemia, and chronic lymphocytic leukemia, as well as aggressive lymphoma, such as diffuse large-B cell lymphoma.
Read more
My research interest is in tumor immunology. I am involved in the development of novel therapies that exploit the immune system as a way to treat cancer. I am the head of hematological malignancies for the Cellular Therapeutics Center, which has played a fundamental role in the development and implementation of CAR T cell therapy. I am also interested in developing targeted therapies for lymphoma and in understanding the mechanisms by which these therapies work.
I am a member of the Waldenström’s macroglobulinemia Clinical Trial Group.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Palomba
- A Phase I Study of Radiation Therapy Before CAR T Cell Therapy for People with B Cell Lymphoma
- A Phase II Study of CLR 131 in People with Central Nervous System Lymphoma
- A Phase II Study of JCAR017 in People with Recurrent or Persistent Follicular Lymphoma or Marginal Zone Lymphoma
- Clinical Trials Co-Investigated by Dr. Palomba
- A Phase 1 Study of a New CAR T Cell Therapy for People With Recurrent or Persistent Large B-Cell Lymphoma
Read more
- A Phase 1 Study of ABBV-525 in People With B-Cell Lymphoma
- A Phase 1/2 Study of MT-101 in People with T-Cell Lymphoma
- A Phase I Study of ALLO-501A, a CAR T Cell Therapy, and ALLO-647, an Antibody, in People with Large B-Cell Lymphoma
- A Phase I Study of BGB-16673 in People with B Cell Cancers
- A Phase I Study of CTX130 Immunotherapy in People with Persistent or Recurrent T-Cell or B-Cell Cancers
- A Phase I Study of FT819 CAR T-Cell Therapy in People with B-Cell Cancers
- A Phase IB Study of Mosunetuzumab in People with Recurrent or Persistent Chronic Lymphocytic Leukemia
- A Phase II Study of MB-CART2019.1 CAR T-Cell Therapy in People with Diffuse Large B-Cell Lymphoma
- A Phase III Study of Ibrutinib with Rituximab in People with Untreated Marginal Zone Lymphoma

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Palomba’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
M. Lia Palomba discloses the following relationships and financial interests:
-
BeiGene, Ltd.
Provision of Services -
Mustang Bio
Provision of Services
-
Novartis
Provision of Services -
Synthekine, Inc.
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].